Showing results (241-250 of 261) with videos related to
Sort By:
Pageof 27
Multiple Sclerosis and Related Disorders|June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trialMitzi J Williams, Annette F Okai, Anne H Cross, et al.Cell|January 14, 2026
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentationJian Wang, Yuhan Qiu, Zoe Marti, et al.Neurology|June 18, 2013
Genetic risk variants in African Americans with multiple sclerosisNoriko Isobe, Pierre-Antoine Gourraud, Hanne F Harbo, et al.Neurology|November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C Klawiter, Riley Bove, Liene Elsone, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 yearsStephen L Hauser, Anne H Cross, Kevin Winthrop, et al.The Lancet. Neurology|September 22, 2024
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trialsXavier Montalban, Patrick Vermersch, Douglas L Arnold, et al.The Journal of Clinical Investigation|January 2, 2025
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populationsClaudia Cantoni, Roman A Smirnov, Maria Firulyova, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple SclerosisRoman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.Pageof 27